| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2023―Jul―30 |
Visualized Analyses of Investigations Upon Mesenchymal Stem/stromal Cell-based Cytotherapy and Underlying Mechanisms for COVID-19 Asso-ciated ARDS |
|
| 2 |
[GO] |
2023―Jul―30 |
Efficacy and Safety of Mesenchymal Stromal Cells Therapy for COVID-19 Infection: A Systematic Review and Meta-analysis |
|
| 3 |
[GO] |
2023―Apr―17 |
Menstrual Blood-Derived Mesenchymal Stem Cell Therapy for Severe COVID-19 Patients |
Zohreh Saltanatpour, Fezzeh Heidari, Mehrdad Nasrollahzadeh Sabet, Reza Heidari, Amir Ali Hamidieh |
| 4 |
[GO] |
2023―Jan―18 |
Mesenchymal stem cells therapy for COVID-19: from basic research to clinical trial |
En-Qiang Chen, Ya-Chao Tao |
| 5 |
[GO] |
2022―Dec―22 |
The role of advanced technologies against COVID-19: Prevention, Detection, and Treatments |
Mozhgan Abasi, Elham Hasanzadeh, Adele Rafati, Seyedeh Masoumeh Seyed Hosseini Tamijani, Raheleh Rafaiee, Ali Golchin |
| 6 |
[GO] |
2022―Nov―25 |
Expediting Molecular Translational Approach of Mesenchymal Stem Cells in COVID-19 Treatment |
K Sreedhara Ranganath Pai, Vignesh Balaji E, Sairaj Satarker, Tanvi V Gujaran, jeena john, Anuranjana P V, Krupa Thankam George, Divya K P, Fathima Beegum, Anna Mathew, R.J.A. Vibhavari, Sneha Sunil Chaudhari |
| 7 |
[GO] |
2022―Oct―18 |
The Promise of Mesenchymal Stem Cells Therapy for Acute Respiratory Distress Syndrome Caused by COVID-19 |
Jundong Gu |
| 8 |
[GO] |
2022―Oct―18 |
Mesenchymal Stem Cell-Based Therapy for COVID-19: Possibility and Potential |
Jing Xiong |
| 9 |
[GO] |
2022―Aug―30 |
Mesenchymal Stem Cells: Case Report of an Adjuvant Ambulatory Therapy for a COVID-19 High-Risk and steroid-hypersensitive Patient |
Juan Pablo Aguilar Alemán, Grecia Andrea Cardoso-Hernández, Ana Luisa Camacho-Torres, Beni Camacho-Pérez, Fabio Antonio Gonzalez-Sanchez, José Navarro-Partida, Rebeca García-Varela, Jesús Aguilar-Aguilar |
| 10 |
[GO] |
2022―Apr―27 |
Mesenchymal Stromal Cells and their EVs as potential leads for SARS-CoV2 treatment |
Vahid Kia, Reza Eshaghi-Gorji, Reyhaneh Nassiri Mansour, Hadi Hassannia, Elham Hasanzadeh, Mobina Gheibi, Amir Mellati, Seyed Ehsan Enderami |
| 11 |
[GO] |
2021―Dec―07 |
Efficacy and Safety of Mesenchymal Stromal cells Therapy for COVID-19 Infection: A Systematic Review and Meta-analysis |
Yaxin Li, Ziyang Wei, Xinyu Ma, Jing Xu, Xia Zhao, Qilong Cao, Guohu Di |
| 12 |
[GO] |
2021―Aug―15 |
Visualized analyses of investigations upon mesenchymal stem/stromal cell-based cytotherapy and underlying mechanisms for COVID-19 associated ARDS |
Wang Aitong, Zhang Leisheng, Yu Hao |
| 13 |
[GO] |
2021―Aug―15 |
The World Against Versatile SARS-Cov-2 Nanomachines; Mythological or Reality? |
Shima Tavakol, Hani Tavakol, Mo S. Alavijeh, Alexander Seifalian |
| 14 |
[GO] |
2020―Nov―26 |
Mesenchymal stem Cells as a Treatment Strategy for Coronavirus Disease 2019 (COVID-19): Need for Authority Regulations and Clinical Guidelines |
Ahmet Cevik Tufan |
| 15 |
[GO] |
2020―Jul―30 |
The Promise of Mesenchymal stem cells therapy for acute Respiratory Distress Syndrome Caused by COVID-19 |
Jundong Gu, Qinjun Zhao, Zhibo Han, Zhongchao Han |
| 16 |
[GO] |
2020―Jul―06 |
Elucidating the Pivotal Role of Immune Players in the Management of COVID-19: Focus on Mesenchymal Stem Cells and Inflammation |
Seidu A. Richard, Sylvanus Kampo, Marian Sackey, Maite Esquijarosa Hechavarria, Alexis D. B. Buunaaim, Eugene Dogkotenge Kuugbee, Thomas Winsum Anabah |
| 17 |
[GO] |
2020―Jun―01 |
Mesenchymal Stem Cell-Based Therapy for COVID-19: Possibility and Potential |
Jing Xiong, Lei Bao, Hongbo Qi, Zhichun Feng, Yuan Shi |
